- RP-HPLCReversed-phase high-performance liquid chromatography
- Reversed-phase HPLC separates a peptide sample on a C18 column by hydrophobicity, under a gradient of increasing acetonitrile in water with a trifluoroacetic acid ion-pair modifier, producing a chromatogram in which the main peak is the target and smaller peaks are synthesis-related impurities. Purity is reported as the main-peak area as a percentage of total integrated absorbance (area-%), typically at 214 nm (the peptide-bond wavelength). It is the first purity screen on a Lyochem lot; it does not by itself prove the sequence.
- ESI-MSElectrospray-ionization mass spectrometry
- Electrospray-ionization mass spectrometry confirms peptide identity by measuring the molecular mass of the ionized molecule and comparing it to the value calculated from the sequence. A standard ion-trap or single-quadrupole instrument typically agrees to within ±0.5 Da, and a high-resolution instrument to within ±0.05 Da, which is tight enough to discriminate against most truncation impurities. ESI-MS confirms molecular weight, not residue order.
- LC-MS/MS sequence verificationTandem mass spectrometry
- LC-MS/MS selects the intact peptide, fragments it along the peptide-bond backbone, and analyses the fragments to reconstruct sequence evidence. Unlike intact-mass MS, it can address residue-order questions. Lyochem can scope it when a buyer's written procedure requires sequence-level evidence; method, reporting, timing, and cost are agreed before quotation.
- b/y-ion ladder
- When a peptide is fragmented in LC-MS/MS, it breaks predominantly into b-type ions (N-terminal fragments) and y-type ions (C-terminal fragments). A complete b/y-ion ladder is the series of these fragments whose successive mass differences read out each residue in order, demonstrating that the synthesized sequence matches the labelled sequence. It is the specific evidence Lyochem reports when sequence-level confirmation is requested.
- Amino acid analysisAAA
- Amino acid analysis hydrolyzes the peptide in acid, separates the released amino acids, and quantifies each to give a measured-versus-theoretical molar ratio per residue. It serves as a composition check orthogonal to HPLC and MS, and it quantifies peptide content independent of any UV extinction-coefficient assumption. Acid hydrolysis destroys tryptophan and combines Asn with Asp and Gln with Glu, so those residues are noted as limitations on the report; Lyochem includes AAA on every commercial lot.
- LAL endotoxin testLimulus Amebocyte Lysate
- The Limulus Amebocyte Lysate test detects bacterial endotoxins (lipopolysaccharides from Gram-negative cell walls) by their reaction with a clotting enzyme, and is reported in endotoxin units per milligram (EU/mg). Endotoxin contamination confounds many metabolic and inflammatory readouts, so it is requested on the specific lot for any cell-culture or in-vivo research use. Lyochem runs LAL on request, with a typical research specification of ≤0.25 EU/mg.
- Karl Fischer water content
- Karl Fischer titration determines the residual water content of a lyophilized peptide, reported as percent water by weight. Residual moisture matters because it affects the true peptide mass per vial and, as a plasticizer, accelerates solid-state degradation pathways such as deamidation and aggregation. Lyochem reports Karl Fischer water on every commercial lot.
- USP <1225>Validation of compendial procedures
- USP General Chapter <1225> describes how an analytical procedure is validated — covering specificity, linearity, accuracy, precision, detection and quantitation limits, range, and robustness. A COA that cites USP <1225> indicates the HPLC, mass-spec, and related tests on the document were run with methods qualified to compendial standards rather than ad-hoc procedures. It is a method-validation reference, not a product or compounding standard.